ImageneBio Inc (IMA)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$4.85-0.82%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · IMA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | — | 0.8 | — | 9.2 | 15.6 | 31.0 | 9.2 |
| Operating Expenses & Income | |||||||
| R&D Expenses | 31.5 | 28.5 | 30.9 | 59.7 | 64.3 | 47.1 | 44.8 |
| Operating Income | (59.0) | (48.5) | (59.0) | (75.4) | (70.9) | (34.1) | (44.5) |
| Earnings from Continuing Operations | |||||||
| Interest & Investment Income | — | — | — | 7.1 | 2.1 | 0.0 | — |
| Other Non-Operating Income / Expenses | 6.2 | 2.8 | 9.9 | 7.1 | — | — | — |
| EBT, Incl. Unusual Items | (52.8) | (45.7) | (49.1) | (68.3) | (68.8) | — | — |
| Income Tax Expense | (0.4) | (0.4) | 0.2 | (0.2) | 0.0 | 0.0 | — |
| Net Income | |||||||
| Net Income | (52.5) | (45.3) | (49.2) | (68.2) | (68.8) | (34.1) | (44.3) |
| Per Share | |||||||
| Basic EPS | — | (9.64) | (1.02) | (1.63) | (1.90) | (1.22) | — |
| Diluted EPS | (3.25) | (9.64) | (1.02) | (1.63) | (1.90) | (1.22) | — |
| Basic Weighted Avg Shares | — | 4.9 | 48.3 | 41.7 | 36.2 | 28.0 | — |
| Diluted Weighted Avg Shares | 16.2 | — | 48.3 | 41.7 | 36.2 | 28.0 | — |
| Supplemental | |||||||
| EBITDA | — | (48.1) | — | — | — | — | — |
| EBIT | (59.0) | (48.5) | (59.0) | (75.4) | (70.9) | (34.1) | (44.5) |
| Effective Tax Rate | 0.7% | — | — | 0.2% | 0.0% | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.